Therapeutic Plasma Exchange to Alleviate Hyperinflammatory Condition During Severe Covid-19 Infections

NCT04751643 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Intensive Care Units
ARDS, Human
Covid19

Interventions

OTHER: Therapeutic plasma exchange : 3 sessions in 3 consecutive days (day 1 to day 3)
OTHER: Usual treatments in intensive care unit according to the current state of knowledge

Sponsor

Hospices Civils de Lyon